A whopping 85% of men experience significantly thinning hair by age 50, and two-thirds experience noticeable hair loss by age ...

By Maggie Fick and Bhanvi Satija LONDON, Feb 24 (Reuters) - With U.S. arch rival Eli Lilly streaking away on weight-loss prescriptions and valuation, the last thing Novo Nordisk needed was to give it ...

Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.

The "Citrus Mechanism" popularized by CitrusBurn in 2026 represents a departure from 20th-century weight loss philosophy.

Novo Nordisk A/S still looks like a buy: oral Wegovy growth, solid global demand, 13x forward P/E, and buybacks support upside. Click for this NVO stock update.

Celltrion aims to join the global race for obesity drugs with an oral pill and an injection for supporting weight loss, the ...

The compounds have exploded in popularity, but big questions about safety and effectiveness are still unresolved.

Elderberry can help boost immune health when taken daily or at the first sign of illness. Find out the best times to take elderberry for immunity.

The best time to take fiber supplements depends on your reason for taking them and how your body responds. Learn more here.

Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound® (tirzepatide) to include the four-dose single-patient use KwikPen® that ...

Feb 23 (Reuters) - Novo Nordisk's next-generation weight-loss drug CagriSema was less effective than Eli Lilly's Zepbound in a head-to-head trial, a fresh blow to the Danish drugmaker's efforts to ...